• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-218、miR-124 和 miR-144 的下调通过激活 NF-κB 信号与帕金森病有关。

Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling.

机构信息

Graduate School, Tianjin Medical University, Tianjin, China.

Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

出版信息

Kaohsiung J Med Sci. 2020 Oct;36(10):786-792. doi: 10.1002/kjm2.12241. Epub 2020 Jun 3.

DOI:10.1002/kjm2.12241
PMID:32492291
Abstract

Parkinson's disease (PD) is a neurological degenerative disorder that is partially induced by inflammation in the neural system. To explore the roles of disordered microRNAs in the development of PD, we screened 10 miRNAs in the brain samples of 15 postmortem PD patients and 10 postmortem healthy controls by qRT-PCR. The direct targets of miRNAs were predicted by informatics tools and further confirmed by dual luciferase assay and immunoblotting. The function of miRNAs in regulating NF-κB/p65 translocation was examined by immunoblotting, and the overactivation of NF-κB signaling was examined by ELISA. The relationship between dysregulated miRNAs and cytokines was analyzed by correlation analysis. Three miRNAs were found to be reduced in the brains of patients with PD. KPNB1, KPNA3, and KPNA4 were identified as direct targets of miR-218, miR-124, and miR-144. Additionally, KPNA3 was identified as a direct target of miR-124, and KPNA4 was a direct target of both miR-124 and miR-218. The p65 translocation from the cytoplasm to the nucleus was repressed by miR-124, miR-218, and miR-144 in the SH-SY5Y cells. The NF-κB signaling pathway was overactivated after miRNA inhibitor transfection. The upregulation of KPNB1, KPNA3, and KPNA4 in the brain samples of PD patients was confirmed by immunoblotting, and negative correlations were found between dysregulated miRNAs and cytokines. In conclusion, we identified that the downregulation of miR-218, miR-124, and miR-144 in the brain was related to PD via activation of NF-κB signaling, helping to unveil the role played by dysregulated miRNAs in the pathogenesis of PD and provide new potential targets for PD treatment.

摘要

帕金森病(PD)是一种神经系统退行性疾病,部分由神经系统炎症引起。为了探索失调的 microRNA 在 PD 发展中的作用,我们通过 qRT-PCR 从 15 名 PD 患者和 10 名尸检健康对照者的脑组织样本中筛选了 10 个 miRNA。利用信息学工具预测 miRNA 的直接靶标,并通过双荧光素酶报告基因实验和免疫印迹进一步验证。通过免疫印迹检测 miRNA 调节 NF-κB/p65 易位的功能,通过 ELISA 检测 NF-κB 信号的过度激活。通过相关性分析分析失调 miRNA 与细胞因子之间的关系。发现三种 miRNA 在 PD 患者的大脑中减少。KPNB1、KPNA3 和 KPNA4 被鉴定为 miR-218、miR-124 和 miR-144 的直接靶标。此外,KPNA3 被鉴定为 miR-124 的直接靶标,而 KPNA4 是 miR-124 和 miR-218 的共同直接靶标。miR-124、miR-218 和 miR-144 在 SH-SY5Y 细胞中抑制 p65 从细胞质向细胞核易位。miRNA 抑制剂转染后 NF-κB 信号通路过度激活。通过免疫印迹证实了 PD 患者脑组织样本中 KPNB1、KPNA3 和 KPNA4 的上调,并且失调 miRNA 与细胞因子之间存在负相关。总之,我们发现大脑中 miR-218、miR-124 和 miR-144 的下调与 PD 通过 NF-κB 信号的激活有关,有助于揭示失调 miRNA 在 PD 发病机制中的作用,并为 PD 治疗提供新的潜在靶点。

相似文献

1
Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling.miR-218、miR-124 和 miR-144 的下调通过激活 NF-κB 信号与帕金森病有关。
Kaohsiung J Med Sci. 2020 Oct;36(10):786-792. doi: 10.1002/kjm2.12241. Epub 2020 Jun 3.
2
Berberine Attenuates MPP-Induced Neuronal Injury by Regulating LINC00943/miR-142-5p/KPNA4/NF-κB Pathway in SK-N-SH Cells.小檗碱通过调节 LINC00943/miR-142-5p/KPNA4/NF-κB 通路减轻 MPP+诱导的 SK-N-SH 细胞损伤。
Neurochem Res. 2021 Dec;46(12):3286-3300. doi: 10.1007/s11064-021-03431-w. Epub 2021 Aug 24.
3
MiR-101 relates to chronic peripheral neuropathic pain through targeting KPNB1 and regulating NF-κB signaling.miR-101 通过靶向 KPNB1 并调节 NF-κB 信号通路与慢性周围神经性疼痛有关。
Kaohsiung J Med Sci. 2019 Mar;35(3):139-145. doi: 10.1002/kjm2.12025.
4
Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson's disease model by targeting the miR-425-5p/TRAF5/NF-κB axis.长链非编码 RNA SNHG7 的下调通过靶向 miR-425-5p/TRAF5/NF-κB 轴保护帕金森病模型中的炎症和细胞凋亡。
J Biochem Mol Toxicol. 2021 Oct;35(10):e22867. doi: 10.1002/jbt.22867. Epub 2021 Aug 8.
5
Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3/-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson's Disease.靶向Akt3介导的GSK-3/β-连环蛋白信号通路的微小RNA-15b-5p下调抑制帕金森病中的细胞凋亡
Biomed Res Int. 2021 Jan 6;2021:8814862. doi: 10.1155/2021/8814862. eCollection 2021.
6
LncRNA SNHG16 promoted proliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis.长链非编码 RNA SNHG16 通过 miR-17-5p/NF-κB 信号通路促进动脉粥样硬化患者巨噬细胞的增殖和炎症反应。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8665-8677. doi: 10.26355/eurrev_201910_19184.
7
[miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].[微小RNA-155-5p通过下调细胞因子信号转导抑制因子1减轻脂多糖诱导的人SH-SY5Y神经母细胞瘤细胞炎症损伤]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Mar;39(3):220-229.
8
KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.受miR-548b-3p调控的KPNA4促进甲状腺乳头状癌的恶性表型。
Life Sci. 2021 Jan 15;265:118743. doi: 10.1016/j.lfs.2020.118743. Epub 2020 Nov 11.
9
MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.微小 RNA-124 调控 MEKK3 在帕金森病炎症发病机制中的表达。
J Neuroinflammation. 2018 Jan 12;15(1):13. doi: 10.1186/s12974-018-1053-4.
10
Long noncoding RNA SNHG14 knockdown exerts a neuroprotective role in MPP-induced Parkinson's disease cell model through mediating miR-135b-5p/KPNA4 axis.长链非编码RNA SNHG14敲低通过介导miR-135b-5p/KPNA4轴在MPP诱导的帕金森病细胞模型中发挥神经保护作用。
Metab Brain Dis. 2022 Oct;37(7):2363-2373. doi: 10.1007/s11011-022-01038-w. Epub 2022 Jul 4.

引用本文的文献

1
Berberine can be a Potential Therapeutic Agent in Treatment of Huntington's Disease: A Proposed Mechanistic Insight.黄连素可能是治疗亨廷顿舞蹈症的一种潜在治疗药物:一种可能的机制性见解。
Mol Neurobiol. 2025 May 16. doi: 10.1007/s12035-025-05054-6.
2
Unlocking Parkinson's disease: the role of microRNAs in regulation, diagnosis, and therapy.揭开帕金森病之谜:微小RNA在调控、诊断及治疗中的作用
Apoptosis. 2025 May 1. doi: 10.1007/s10495-025-02117-w.
3
The Role of miR-144 in Inflammatory Diseases: A Review.miR-144在炎症性疾病中的作用:综述

本文引用的文献

1
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.帕金森病中的自身免疫:α-突触核蛋白特异性 T 细胞的作用。
Front Immunol. 2019 Feb 25;10:303. doi: 10.3389/fimmu.2019.00303. eCollection 2019.
2
Oxidative stress and cellular pathologies in Parkinson's disease.帕金森病中的氧化应激和细胞病理学。
Mol Brain. 2017 Nov 28;10(1):53. doi: 10.1186/s13041-017-0340-9.
3
Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.血浆中miR-137和miR-124的水平与帕金森病相关,但与伴发抑郁的帕金森病无关。
Immun Inflamm Dis. 2025 Mar;13(3):e70172. doi: 10.1002/iid3.70172.
4
Role of exercise on ncRNAs and exosomal ncRNAs in preventing neurodegenerative diseases: a narrative review.运动对非编码RNA和外泌体非编码RNA在预防神经退行性疾病中的作用:一项叙述性综述
Mol Med. 2025 Feb 7;31(1):51. doi: 10.1186/s10020-025-01091-y.
5
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases.线粒体微小核糖核酸:揭示神经退行性疾病的关键驱动因素
Int J Mol Sci. 2025 Jan 13;26(2):626. doi: 10.3390/ijms26020626.
6
Cohort-specific boolean models highlight different regulatory modules during Parkinson's disease progression.特定队列的布尔模型在帕金森病进展过程中突出了不同的调控模块。
iScience. 2024 Sep 14;27(10):110956. doi: 10.1016/j.isci.2024.110956. eCollection 2024 Oct 18.
7
MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.微小RNA在帕金森病中的调控及其作为诊断和治疗靶点的潜在作用。
NPJ Parkinsons Dis. 2024 Oct 5;10(1):186. doi: 10.1038/s41531-024-00791-2.
8
An Overview of Epigenetic Changes in the Parkinson's Disease Brain.帕金森病大脑中的表观遗传学改变概述。
Int J Mol Sci. 2024 Jun 3;25(11):6168. doi: 10.3390/ijms25116168.
9
Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies.帕金森病和突触核蛋白病中神经元功能障碍及非编码RNA对基因的调控
Front Cell Neurosci. 2024 Jan 5;17:1328269. doi: 10.3389/fncel.2023.1328269. eCollection 2023.
10
MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.MicroRNA-218-5p-Ddx41 轴通过下调帕金森病小鼠模型中 I 型干扰素反应来抑制小胶质细胞介导的神经炎症。
J Transl Med. 2024 Jan 16;22(1):63. doi: 10.1186/s12967-024-04881-w.
Neurol Sci. 2017 May;38(5):761-767. doi: 10.1007/s10072-017-2841-9. Epub 2017 Feb 8.
4
Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.异补骨脂查耳酮通过NF-κB途径抑制小胶质细胞活化减轻MPTP诱导的小鼠帕金森病。
PLoS One. 2017 Jan 6;12(1):e0169560. doi: 10.1371/journal.pone.0169560. eCollection 2017.
5
microRNA Profiles in Parkinson's Disease Prefrontal Cortex.帕金森病前额叶皮质中的微小RNA谱
Front Aging Neurosci. 2016 Mar 1;8:36. doi: 10.3389/fnagi.2016.00036. eCollection 2016.
6
MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.miRNA-124 将 p53 与 B 细胞淋巴瘤中的 NF-κB 通路联系起来。
Leukemia. 2015 Sep;29(9):1868-74. doi: 10.1038/leu.2015.101. Epub 2015 Apr 27.
7
Parkinson's disease.帕金森病。
Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.
8
Parkinson's disease and enhanced inflammatory response.帕金森病与增强的炎症反应。
Exp Biol Med (Maywood). 2015 Nov;240(11):1387-95. doi: 10.1177/1535370215576313. Epub 2015 Mar 13.
9
Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance.人内侧颞叶癫痫和海马硬化中 miR-218 和 miR-204 的异常表达——集中于轴突导向。
Epilepsia. 2014 Dec;55(12):2017-27. doi: 10.1111/epi.12839. Epub 2014 Nov 19.
10
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.在MPTP处理的帕金森病小鼠模型和碘代MPP处理的MN9D细胞中,miR-124的下调调节了钙蛋白酶/细胞周期蛋白依赖性激酶5(calpain/cdk5)信号通路蛋白的表达。
Neuroscience. 2014 Jul 11;272:167-79. doi: 10.1016/j.neuroscience.2014.04.039. Epub 2014 Apr 30.